Malignancies after pediatric solid organ transplantation

Area of Science:

• Oncology
• Transplantation Medicine
• Pediatric Health

Background:

• Improved life expectancy in pediatric solid organ transplant recipients (SOTRs) leads to increased risks of post-transplantation malignancies.
• SOTRs have elevated risks for post-transplantation lymphoproliferative disorders (PTLDs) and both skin and solid cancers.
• Cancer incidence reaches 26-41% by 30 years post-transplantation, with PTLDs occurring early and other cancers in young adulthood.

Purpose of the Study:

• To highlight the increased risk of malignancy in pediatric SOTRs.
• To discuss the distinct risk factors and timing for different cancer types post-transplantation.
• To emphasize the need for tailored cancer screening and prevention strategies in this population.

Main Methods:

• Review of existing literature on post-transplant malignancies in pediatric SOTRs.
• Analysis of risk factors including immunosuppression, infections, organ type, and underlying disease.
• Evaluation of current treatment and prevention strategies.

Main Results:

• PTLDs and skin/solid cancers are significant long-term risks for pediatric SOTRs.
• Risk factors are multifactorial, influenced by immunosuppression intensity, infections, and transplant specifics.
• Cancer treatment requires balancing efficacy with risks of rejection and allograft loss.

Conclusions:

• Current cancer screening guidelines for the general population are not validated for pediatric SOTRs.
• An individualized approach to cancer screening is essential, considering unique patient risk profiles.
• Prevention strategies like lifestyle counseling and vaccinations are vital components of care.